Keravision Inc/DE – ‘8-K’ for 4/19/99

As of:  Monday, 4/19/99   ·   For:  4/19/99   ·   Accession #:  946154-99-8   ·   File #:  0-26316

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         3     13K 
 2: EX-99.16    News Release Dated 4/12/99                             3±    14K 
 3: EX-99.17    News Release Dated 4/12/99                             3±    13K 
 4: EX-99.18    News Release Dated 4/12/99                             3±    13K 
 5: EX-99.19    News Release Dated 4/14/99                             2±    12K 
 6: EX-99.20    News Release Dated 4/15/99                             3±    13K 
 7: EX-99.21    News Release Dated 4/15/99                             2±    12K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                       Total Number of Pages:  3
                                                                              --

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: April 19, 1999  

Commission File Number:  0-26208

================================================================================

KERAVISION, INC.

(Exact name of Registrant as specified in its Charter)

DELAWARE                                               77-0328942     
(State of Incorporation)                                 (I.R.S. Employer       
                                                   Identification No.)

48630 MILMONT DRIVE 
FREMONT, CA  94538
(Address of principal executive offices)

(510) 353-3000
(Registrant's telephone number) 

8-K
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ITEM 5.  OTHER EVENTS                                                           

On April 12, 1999, KeraVision, Inc. announced FDA Grants Pre-market       
Approval (PMA) to Intacs, KeraVision's Non-Laser Option for treating            
Myopia.  Further details regarding this announcement are contained              
in the Company's new release dated April 12, 1999,  attached as exhibit         
hereto and incorporated reference herein.                                       

On April 12, 1999, KeraVision, Inc. annouced that Keravision and Aris     
Sign Agreement to Offer Intacs in Four Markets.  Further details regarding this 
announcement are contained in the Company's new release dated April 12, 1999,   
attached as exhibit hereto and incorporated reference herein.                   

On April 12, 1999, KeraVision, Inc. annouced that Keravision and Novamed  
Sign Agreement to Offer Intacs in Five Metropolitan  Markets.  Further details  
regarding this announcement are contained in the Company's new release dated    
April 12, 1999, attached as exhibit hereto and incorporated reference herein.   

On April 14, 1999, KeraVision, Inc.  Presented One-Year Clinical Data     
On Intacs for Hyperopia. Further details regarding this announcement are        
contained in the Company's new release dated April 14, 1999,  attached as       
exhibit hereto and incorporated reference herein.                               

On April 15, 1999, KeraVision, Inc.  annouced Sales of KeraVision Intacs  
Begin; Non-Laser Surgical Option For Treating Myopia Represents a New           
Category of Vision Correction.  Further details regarding this annoucement      
are contained in the Company's new released dated April 15, 1999, attached      
as exhibit hereto and incorporated reference herein.                            

On April 15, 1999, KeraVision, Inc.  annouced Distribution Deal With      
Laser Vision Centers, Inc. For Intacs Treatment in 40 States.  Further          
details regarding this annoucement are contained in the Company's new           
released dated April 15, 1999, attached as exhibit hereto and incorporated      
reference herein.                                                               

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS     

(a)   Exhibits:                                               

            99.16 KeraVision, Inc. News Release dated April 12, 1999

            99.17 KeraVision, Inc. News Release dated April 12, 1999

            99.18 KeraVision, Inc. News Release dated April 12, 1999

            99.19 KeraVision, Inc. News Release dated April 14, 1999

            99.20 KeraVision, Inc. News Release dated April 15, 1999

            99.21 KeraVision, Inc. News Release dated April 15, 1999

2 

8-K
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the    
undersigned thereunto duly authorized.                                          

        KERAVISION, INC.

               /s/Mark Fischer-Colbrie
               -----------------------
            Mark Fischer-Colbrie
                   Vice President, Finance and
                          Administration and Chief Financial
                       Officer(Principal Financial and
           Accounting Officer)

Date: April 19, 1999                                                            

3 

Dates Referenced Herein

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on / For Period End:		4/19/99		1		3			None on these Dates
		4/15/99		2
		4/14/99		2
		4/12/99		2
									List all Filings